Hong Kong
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.56 B
|
Dec. 31, 2023 | USD 0.67 | 1.15% |
|
Hong Kong |
|
2 |
USD 814.92 M
|
Dec. 31, 2023 | USD 0.38 | 2.08% |
|
Hong Kong |
|
3 |
USD 463.30 M
|
Dec. 31, 2023 | USD 1.48 | 0.68% |
|
Hong Kong |
|
4 |
USD 382.10 M
|
Dec. 31, 2023 | USD 0.93 | 2.39% |
|
Hong Kong |
|
5 |
USD 209.83 M
|
Dec. 31, 2023 | USD 0.41 | 0.30% |
|
Hong Kong |
|
6 |
USD 201.03 M
|
Dec. 31, 2023 | USD 0.25 | -2.07% |
|
Hong Kong |
|
7 |
USD 120.78 M
|
March 31, 2024 | USD 0.46 | 4.31% |
|
Hong Kong |
|
8 |
USD 79.91 M
|
Dec. 31, 2023 | USD 1.07 | 3.09% |
|
Hong Kong |
|
9 |
USD 68.97 M
|
Dec. 31, 2023 | USD 0.52 | 0.23% |
|
Hong Kong |
|
10 |
USD 60.76 M
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
11 |
USD 48.85 M
|
March 31, 2024 | USD 0.27 | 0.46% |
|
Hong Kong |
|
12 |
USD 43.09 M
|
Dec. 31, 2023 | USD 0.43 | -0.61% |
|
Hong Kong |
|
13 |
USD 39.94 M
|
Dec. 31, 2023 | USD 0.44 | 1.16% |
|
Hong Kong |
|
14 |
USD 28.01 M
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
15 |
USD 20.21 M
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
16 |
USD 18.38 M
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
17 |
USD 6.00 M
|
Dec. 31, 2023 | USD 0.80 | 2.57% |
|
Hong Kong |
|
18 |
USD 4.61 M
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
19 |
USD -4.74 M
|
June 30, 2024 | USD 3.80 | 0.53% |
|
Hong Kong |
|
20 |
USD -32.34 M
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
21 |
USD -51.91 M
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
22 |
USD -77.15 M
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
|
23 |
USD -1.21 B
|
Dec. 31, 2023 | USD 17.19 | 2.12% |
|
Hong Kong |
The Healthcare company in Hong Kong with the highest Operating Income is China Resources Pharmaceutical Group Limited (HKSE: 3320.HK) at USD 1.56 B.
The Healthcare company in Hong Kong with the lowest Operating Income is BeiGene, Ltd. (HKSE: 6160.HK) at USD -1.21 B.
The top 10 Healthcare companies in Hong Kong by Operating Income are China Resources Pharmaceutical Group Limited, Sino Biopharmaceutical Limited, The United Laboratories International Holdings Limited, China Medical System Holdings Limited, SSY Group Limited, China Traditional Chinese Medicine Holdings Co. Limited, Alibaba Health Information Technology Limited, Beijing Tong Ren Tang Chinese Medicine Company Limited, Modern Dental Group Limited and Dawnrays Pharmaceutical (Holdings) Limited.
The bottom 10 Healthcare companies in Hong Kong by Operating Income are BeiGene, Ltd., Sirnaomics Ltd., Prenetics Global Limited, SinoMab BioScience Limited, Regencell Bioscience Holdings Limited, Lee's Pharmaceutical Holdings Limited, Guangdong Hybribio Biotech Co.,Ltd., HUTCHMED (China) Limited, Frontage Holdings Corporation and Jilin Province Huinan Changlong Bio-pharmacy Company Limited.